Swiss Medica Awards North American Launch of O24 To Holmes & Lee.Business Editors/Health/Medical Writers TORONTO--(BUSINESS WIRE)--Sept. 3, 2003 Swiss Medica medica (māˑ·dē·k Inc. has awarded the launch of its O24 Pain Relief product to Holmes & Lee - Advertising, Design & Interactive, of Toronto, Ontario. O24 is a patented, natural essential oil pain relief product first introduced in Europe for application in the sports, hospital and medical communities. "We intend to launch O24 Pain Relief throughout North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. this fall with a mainstream consumer effort through multiple channels" stated Raghu Kilambi, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Swiss Medica Inc. "Holmes & Lee have a proven history in providing strong, blue chip brands like Second Cup Coffee Company, Canada Trust CT Financial Services Inc. was a financial services holding company that was founded in London, Ontario and later had its headquarters in Toronto, Ontario and operated in Canada through subsidiaries including Canada Trustco Mortgage Company and The Canada Trust Company , Sears Canada Sears Canada Inc. TSX: SCC (more commonly referred to as "Sears") is a retailer, headquartered in Toronto, Ontario, that operates in all provinces and territories across Canada with a network of 188 corporate stores, 180 dealer stores, 67 home improvement showrooms, 112 Sears and Land Rover with exceptional creative work. We were particularly impressed with their experience in providing successful sales positions for OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). products like Clearblue Easy, Nettlemax and Delsym Cough Remedy with effective communications efforts." Holmes & Lee will provide an evolved identity for O24, from logo and package design, to television advertising and promotion, to interactive support. "It is rare that we get a chance to become deeply involved with a product so early in the game - especially a product that we absolutely believe is a "category killer Category Killer Large companies that put less efficient and highly specialized merchants out of business. Category killers can attain this status by being cheaper, easier, bigger, or more popular than the competition. ", said John Lee, President of Holmes & Lee. "It is an excellent opportunity, and we are very excited about O24's potential in North America." About Swiss Medica Inc. Swiss Medica Inc. is focused on acquiring over-the-counter bioscience products with demonstrated competitive advantages and increasing their revenues by focused sales and marketing efforts in selected distribution channels including retail, direct sales, direct response, and e-commerce. Swiss Medica's mission is to be a world leader in the acquisition and commercialization of life enhancing bioscience products that improve quality of lives. Please visit our website at www.swissmedica.com About Holmes & Lee Holmes & Lee is a company with a simple mission. Make their clients brands best of category". The company has successfully achieved this mission with fully integrated and orchestrated campaigns for their clients in the retail, packaged goods, automotive, fashion, tourism, alcohol beverages, food, pharmaceutical, institutional and media areas. With founding partners Peter Holmes and John Lee in the lead, Holmes & Lee provide a strong strategic and creative product that has provided both great results and industry acknowledgment for their clients. www.holmesandlee.com Forward-looking statements in this news release are made pursuant to the "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the United States Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's services, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion